Background: Both hypo-and hyperkalemia are associated with adverse events in heart
failure patients. Their effects on patients with left ventricular assist devices (LVADs) remains …

Hyponatremia is associated with increased morbidity and mortality in heart failure (HF)
patients. The implication of hyponatremia during left ventricular assist device (LVAD) therapy …

Introduction Hyponatremia is common in heart failure and is a well-established indicator of
adverse outcomes. The clinical implication of hyponatremia in left ventricular assist device …

Background Serum sodium is an independent predictor of worsening outcomes in patients
with advanced heart failure. It is unclear how sodium levels are affected by left ventricular …

Serum sodium is an established prognostic marker in heart failure (HF) patients and is
associated with an increased risk of morbidity and mortality. We sought to study the …

Introduction Serum sodium is an important prognostic marker in heart failure patients, with
lower values associated with increased risk of mortality. However, prognostic value of serum …

Hyponatremia is a well-established marker of adverse outcomes in chronic heart failure (HF)
but not well studied in patients with left ventricular assist device (LVAD). This is a …

Background Hyponatremia is associated with adverse outcomes in heart failure and after
cardiac surgery. We hypothesized that hyponatremia is associated with poorer short‐term …

Background This study aimed to comprehensively analyze the relationship between serum
potassium (K+) levels and the risk of de novo cardiac arrhythmias in left ventricular assist …

Introduction Left ventricular assist devices (LVADs) are becoming more commonly used in
patients with advanced heart failure, either as a temporary bridge to heart transplantation or …